Review
Published on 16 Aug 2022
Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.911906
- 5,861 views
- 8 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,601 articles
Articles
Case Report
Published on 16 Aug 2022
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.954886
- 2,565 views
- 9 citations
Original Research
Published on 15 Aug 2022
A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.916889
- 1,895 views
- 4 citations
Original Research
Published on 15 Aug 2022
The nomogram for the prediction of overall survival in patients with metastatic lung adenocarcinoma undergoing primary site surgery: A retrospective population-based study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.916498
- 2,534 views
- 5 citations
Original Research
Published on 12 Aug 2022
Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.827199
- 2,909 views
- 6 citations
Original Research
Published on 12 Aug 2022
Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.935184
- 2,670 views
- 9 citations
Review
Published on 12 Aug 2022
Choosing the optimal immunotherapeutic strategies for non-small cell lung cancer based on clinical factors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.952393
- 3,770 views
- 4 citations
Original Research
Published on 11 Aug 2022
A radiomics nomogram for invasiveness prediction in lung adenocarcinoma manifesting as part-solid nodules with solid components smaller than 6 mm
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.900049
- 1,796 views
- 3 citations
Case Report
Published on 11 Aug 2022
Personalized treatment of extensive stage small cell lung cancer: A case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.956372
- 2,646 views
Review
Published on 11 Aug 2022
Current treatments for non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.945102
- 16,434 views
- 54 citations
Original Research
Published on 11 Aug 2022
Microwave ablation with local pleural anesthesia for subpleural pulmonary nodules: our experience
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.957138
- 2,358 views
- 3 citations
Original Research
Published on 10 Aug 2022
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.980765
- 3,824 views
- 7 citations
Original Research
Published on 10 Aug 2022
Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.890033
- 2,407 views
- 7 citations
Original Research
Published on 10 Aug 2022
The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.954317
- 2,029 views
- 7 citations
Systematic Review
Published on 10 Aug 2022
Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.883514
- 1,859 views
- 1 citation
Original Research
Published on 10 Aug 2022
Development and validation of a deep learning model to predict survival of patients with esophageal cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.971190
- 4,579 views
- 12 citations